ViGenCell (308080.KQ) Stock Price

ViGenCell Price

CLOSED
5,440.00
​
Market closed

Revenue has compounded at 7.1% per year over the past 6 years to 22.67 M KRW. ViGenCell's net margin stands at -71,986.4%, up from -149,218.8% several years earlier.

ViGenCell stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ViGenCell business model & stock analysis

ViGenCell Inc is a biotechnology company based in Seoul, South Korea, operating within the Health Care sector. The company has 80 employees and completed its initial public offering (IPO) on August 25, 2021. ViGenCell focuses on research and development in natural science and engineering, with a particular emphasis on cell therapy technologies. The company develops and manufactures immuno-cancer cell therapy products and immunosuppressive cell therapy products. It also provides the Vitier platform, which is an antigen-specific killing T cell treatment, the Viranger platform for gamma delta T cell gene therapy, and the Vimedier platform-based technology for myeloid suppressor cell therapy derived from umbilical cord blood. ViGenCell is engaged in the research and development of new drugs targeting conditions such as acute myeloid leukemia (AML) and glioblastoma. The company's website is https://www.vigencell.com/. ViGenCell Inc is listed on the Korean stock market under the ticker 308080.KQ and has the ISIN KR7308080001. The company's headquarters are located in Seoul, South Korea.

Frequently asked questions about ViGenCell

Converted at the current exchange rate, the ViGenCell share trades at 3.62 EUR (5,440.00 KRW).

The revenue cannot currently be calculated for ViGenCell.

The profit cannot currently be calculated for ViGenCell.

The P/E ratio cannot be calculated for ViGenCell at the moment.

The P/S cannot be calculated for ViGenCell currently.

The Eulerpool Quality Score for ViGenCell is 2/10.

The ISIN of ViGenCell is KR7308080001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of ViGenCell is 308080.KQ. The ticker symbol is used to trade ViGenCell shares on the stock exchange.

Fair ValueTerminal
4,624.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
283,428.75 KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Aug 25, 2021
ISIN
KR7308080001
Cusip
Y9330Y100
Market capitalization
104.62 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
2.39
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-31.93 %
Last updated Oct 18, 2026, 12:20 PM

ViGenCell Peer Group

ViGenCell FIGI

308080:KS · BBG00DGZS9M2308080:KQ · BBG011MCLJD6

All fundamentals and in-depth analysis of ViGenCell

Our stock analysis for ViGenCell stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ViGenCell. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.